Kleiber H, Munger R, Jallut D, Tappy L, Felley C, Golay A, Frascarolo P, Jéquier E, Felber J P
Department of Internal Medicine, University Hospital, Lausanne, Switzerland.
Diabete Metab. 1992 Mar-Apr;18(2):84-90.
The present work was planned to study the effects of changes in lipid metabolism irrespective of FFA concentrations (FFA) on the regulation of oxidative and nonoxidative disposal of a glucose infusion during hyperinsulinaemia. Fifteen normal volunteers participated in the 3 protocols, in which 1) Intralipid 2) beta-pyridylcarbinol or 3) isotonic saline were infused during 2 hours. Thereafter, these infusions were discontinued and a two-hour euglycaemic hyperinsulinaemic clamp was performed. All three studies were carried out in combination with indirect calorimetry to measure glucose uptake, and oxidative and nonoxidative glucose disposal (corresponding essentially to glucose storage). Plasma FFA concentrations were 508 +/- 34, 601 +/- 43 and 546 +/- 45 mumol/l in the basal state during the Intralipid, beta-pyridylcarbinol and control protocols. It increased to 960 +/- 71 mumol/l after the Intralipid infusion, fell to 246 +/- 17 mumol/l after the beta-pyridylcarbinol infusion, vs 600 +/- 48 mumol/l in the control. At the end of the glucose-insulin clamp the values were low in the 3 protocols: 263 +/- 17, 233 +/- 19 and 204 +/- 14 mumol/l. Intralipid infusion prior to the clamp protocol induced a suppression of both insulin-mediated glucose uptake (4.91 +/- 0.46 (Intralipid) vs 6.83 +/- 0.63 mg.kg-1.min-1 (saline)) and storage (1.61 +/- 0.34 vs 2.99 +/- 0.53 mg.kg-1.min-1) while beta-pyridylcarbinol infusion induced an increased insulin-mediated glucose uptake (8.58 +/- 0.37 mg.kg-1.min-1) and in glucose storage (4.29 +/- 0.31 mg.kg-1.min-1) (p less than 0.5 vs Intralipid). These changes occurred even though FFA plasma concentrations were similar in the 3 experimental conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在探讨脂质代谢变化(不考虑游离脂肪酸浓度)对高胰岛素血症期间葡萄糖输注的氧化和非氧化处理调节的影响。15名正常志愿者参与了3个方案,在这些方案中,分别在2小时内输注1)英脱利匹特、2)β-吡啶甲醇或3)等渗盐水。此后,停止这些输注,并进行两小时的正常血糖高胰岛素钳夹试验。所有三项研究均结合间接测热法进行,以测量葡萄糖摄取以及氧化和非氧化葡萄糖处理(基本上对应于葡萄糖储存)。在英脱利匹特、β-吡啶甲醇和对照方案的基础状态下,血浆游离脂肪酸浓度分别为508±34、601±43和546±45μmol/L。英脱利匹特输注后升至960±71μmol/L,β-吡啶甲醇输注后降至246±17μmol/L,而对照为600±48μmol/L。在葡萄糖-胰岛素钳夹试验结束时,三个方案中的值均较低:263±17、233±19和204±14μmol/L。钳夹方案前输注英脱利匹特会抑制胰岛素介导的葡萄糖摄取(英脱利匹特组为4.91±0.46,盐水组为6.83±0.63mg·kg⁻¹·min⁻¹)和储存(分别为1.61±0.34和2.99±0.53mg·kg⁻¹·min⁻¹),而输注β-吡啶甲醇会使胰岛素介导的葡萄糖摄取增加(8.58±0.37mg·kg⁻¹·min⁻¹)和葡萄糖储存增加(4.29±0.31mg·kg⁻¹·min⁻¹)(与英脱利匹特组相比,p<0.5)。尽管在三种实验条件下血浆游离脂肪酸浓度相似,但仍出现了这些变化。(摘要截断于250字)